ResMed Inc (RMD)

Net profit margin

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net income (ttm)	US$ in thousands	1,020,950	958,378	890,386	906,500	897,556	862,953	809,465	786,302	779,437	779,476	521,983	499,746	474,505	457,240	698,858	679,898	621,674	512,640	454,919	419,004
Revenue (ttm)	US$ in thousands	4,681,240	4,528,920	4,442,900	4,314,610	4,171,410	4,064,591	3,819,396	3,688,938	3,645,890	3,606,884	3,513,684	3,419,445	3,265,514	3,144,973	3,128,793	3,045,837	2,957,056	2,891,676	2,784,449	2,699,392
Net profit margin		21.81%	21.16%	20.04%	21.01%	21.52%	21.23%	21.19%	21.32%	21.38%	21.61%	14.86%	14.61%	14.53%	14.54%	22.34%	22.32%	21.02%	17.73%	16.34%	15.52%

June 30, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,020,950K ÷ $4,681,240K
= 21.81%

Over the past few quarters, ResMed Inc has demonstrated relatively stable net profit margins, ranging from around 14.5% to 22.3%. The company's net profit margin peaked at 22.34% in March 2021 and dropped to its lowest point at 14.53% in March 2022.

In recent quarters, the net profit margin has been consistently above 20%, indicating that ResMed Inc has been effective in controlling its costs and generating profits relative to its revenue. This trend suggests that the company has been successful in managing its expenses and operational efficiency.

Overall, ResMed Inc's net profit margin performance reflects a healthy level of profitability and financial management, which may be reassuring to investors and stakeholders. It will be important to continue monitoring this metric to assess the company's financial health and sustainability.